Researchers at Vanderbilt University say a group of alpacas in Tennessee could be the key to cure autism, Alzheimer's and even cancer. The happy herd at Litton Farms in Waverly could potentially save lives as researchers try to harness their power to create antibodies. Those antibodies will be used to study human disease and potentially treat human patients, Vanderbilt said in a news release. Antibodies from these Alpacas can be used to "visualize and potentially regulate" the PPP2R5D enzyme, which researchers said has been linked to autism, Alzheimer’s disease and some cancers.
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today announced second quarter 2019 financial results with net revenues of $11.6 million, up 14% over the prior year quarter. Year-to-date net revenues were $23.5 million, up 25% from the prior year period.
The Quillen College of Medicine at East Tennessee State University is among a small group of medical schools across the U.S. with programs dedicated to bolstering the number of primary care doctors in rural communities. The schools send students to live in small towns and train with rural doctors. Like Quillen, some also organize outings and cultural experiences to try to sell students on living there after they graduate. Most of the students who came to Quillen did not grow up or attend school in rural areas, but all expressed an interest in working with underserved populations, rural programs coordinator Carolyn Sliger said.
Although startups based in California, New York, and Massachusetts have traditionally accounted for the majority of VC tech investment in the US, VCs are spurring other hotbeds of innovation across the country. Using their data, CB Insights analyzed the most active venture capital firm in each state. They based their selection on which VC had invested in the greatest number of tech startups located in a certain state from 2014 to 2019 YTD (8/7/2019). CB Insights excluded debt deals and only considered venture capital, corporate venture capital, super angel and growth equity firms. In the case of a tie, they used recency of deals, overall deal activity and investor quality to select the most active tech startup investor for that state. Check out the full list of VCs featured.
For the first time, a BioTalk look inside BioHealth Innovation, Inc. (BHI) with Entrepreneur-In-Residence (EIR) Dr. Ethel Rubin. Dr. Ethel Rubin leads a venture team that helps prepare and connect life science companies with capital, ensuring strategies that hit valuation inflection points, achieve strategic goals and prepare for a product launch.